This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours (GMAIS)

This study has been completed.
Sponsor:
Collaborators:
University of California, Los Angeles
Huntington Hospital
Hoag Memorial Hospital Presbyterian
Columbia University
California Pacific Medical Center Research Institute
University Hospital Erlangen
Sarasota Memorial Hospital
University of Louisville
Information provided by (Responsible Party):
Genervon Biopharmaceuticals, LLC
ClinicalTrials.gov Identifier:
NCT01221246
First received: October 11, 2010
Last updated: August 1, 2017
Last verified: August 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 7, 2016
  Primary Completion Date: July 7, 2016 (Final data collection date for primary outcome measure)